Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 62,694 | 69,424 | 73,712 | 67,375 | 63,279 |
| Operating Income | -62,694 | -69,424 | -73,712 | -67,375 | -63,279 |
| Interest Expense | 473 | 471 | 471 | 471 | 470 |
| Other Income | 2,840 | 3,176 | 4,537 | 5,792 | 4,089 |
| Pre-tax Income | -60,327 | -66,719 | -69,646 | -62,054 | -59,660 |
| Net Income Continuous | -60,327 | -66,719 | -69,646 | -62,054 | -59,660 |
| Net Income | $-60,327 | $-66,719 | $-69,646 | $-62,054 | $-59,660 |
| EPS Basic Total Ops | -0.62 | -0.71 | -0.74 | -0.66 | -0.62 |
| EPS Basic Continuous Ops | -0.61 | -0.71 | -0.74 | -0.66 | -0.62 |
| EPS Diluted Total Ops | -0.62 | -0.71 | -0.74 | -0.66 | -0.62 |
| EPS Diluted Continuous Ops | -0.61 | -0.71 | -0.74 | -0.66 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -0.62 | -0.71 | -0.74 | N/A | N/A |
| EBITDA(a) | $-60,333 | $-67,035 | $-71,341 | $-65,121 | $-54,268 |